Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[An animal model of posttraumatic multiple system organ failure (MSOF)].

S Hu1

  • 1Trauma Center, Postgraduate Medical College, PLA 304th Hospital, Beijing.

Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi = Zhonghua Zheng Xing Shao Shang Waikf [I.E. Waike] Zazhi = Chinese Journal of Plastic Surgery and Burns
|March 1, 1992
PubMed
Summary

This study successfully created an animal model for Multiple System Organ Failure (MSOF) by combining trauma and supportive care. This model aids in studying MSOF mechanisms and potential therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Onychomatricoma has channel-like structures on in vivo reflectance confocal microscopy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2013
Same author

Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: results of an exploratory analysis.

Breast (Edinburgh, Scotland)·2013
Same author

Overexpression of nuclear β-catenin at invasive front in rectal carcinoma is associated with lymph node metastasis and poor prognosis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2013
Same author

A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers.

Minerva medica·2013
Same author

Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice.

Neuroscience·2013
Same author

CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.

Journal of applied microbiology·2013

Area of Science:

  • Trauma and Critical Care Medicine
  • Pathophysiology Research
  • Animal Modeling

Context:

  • Multiple System Organ Failure (MSOF) is a critical complication following severe trauma, burns, sepsis, or inflammation.
  • Intestinal mucosal barrier dysfunction is a key factor contributing to MSOF development.
  • Existing research lacks adequate animal models to fully replicate MSOF's clinical and pathological features.

Purpose:

  • To establish a reproducible animal model that simulates the clinical and pathological characteristics of Multiple System Organ Failure (MSOF).
  • To investigate the potential of compounded traumatic factors, including bowel damage, in inducing MSOF.
  • To provide a foundation for studying MSOF mechanisms and evaluating therapeutic interventions.

Summary:

Related Experiment Videos

  • This research details the successful development of an animal model for Multiple System Organ Failure (MSOF).
  • The model was created by inducing compounded traumatic factors, including bowel injury, coupled with essential circulatory and respiratory support.
  • The study confirmed that this approach effectively reproduces the pathophysiology and histopathology of MSOF, offering a valuable platform for further investigation.

    • Impact:

    • Provides a novel animal model for studying the complex mechanisms underlying Multiple System Organ Failure (MSOF).
    • Facilitates the preclinical evaluation of new therapeutic strategies for MSOF.
    • Contributes to a better understanding of MSOF development in critical care settings, potentially improving patient outcomes.